Navigation Links
GTG Announces New Product Collaboration with Global Pharmaceutical Company for Companion Diagnostics in Oncology
Date:4/19/2011

ses of non-coding DNA in genetic analysis and gene mapping across all genes in all species.  Its business strategy is the global commercialization of its patents through an active out-licensing program and the global expansion of its oncology and cancer management diagnostics portfolio. Genetic Technologies is an ASX and NASDAQ listed company with operations in the USA and Australia. For more information, please visit www.gtglabs.com.

Safe Harbor StatementAny statements in this press release that relate to the Company's expectations are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Since this information may involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. Additional risks associated with Genesis Bioventures' business can be found in its periodic filings with the SEC.ENQUIRIESDr Paul D R MacLeman

Rudi Michelson (Australia)

Seth Lewis (USA)Chief Executive Officer

Monsoon Communications

Trout Group Inc.Genetic Technologies Limited

(03) 9620 3333

(646) 378 2952Phone: +61 3 8412 7000
'/>"/>

SOURCE Genetic Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangart Announces Closing of $50 Million Series G Financing
2. MiMedx Group, Inc. Announces Release Date for First Quarter Results
3. Awarepoint Corporation Announces Acquisition of PCTS
4. Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences
5. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
6. CryoLife Announces Release Date and Teleconference Call Details for 2011 First Quarter Financial Results
7. Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
8. American Scientific Resources, Inc. Announces Corporate Update
9. Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
10. CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation
11. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... and NEW YORK , October 1, 2014 /PRNewswire/ ... (CRO) and service provider for the medical industries, announced today the ... in New York City . genae Americas was ... is strategically centered in one of the highest concentrations of ... Philippe Kassab , President at genae Americas. "The expansion of ...
(Date:10/1/2014)... , Oct. 1, 2014  Varian Medical Systems (NYSE: ... report results for the fourth quarter of fiscal year ... October 22, 2014.  The news release will be followed ... 2:00 p.m. PT.  The news release and a link ... the company website at: www.varian.com/investor .  To access ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
Breaking Medicine Technology:genae Opens Offices in New York City 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3
... Medical School ,Contributing Editor , ,With over ... breast cancer undoubtedly qualifies as one of Americas ... develop early detection methods and more effective therapy ... true at the molecular level, where discoveries on ...
... located on the short arm of chromosome 6 (6p21.3), is ... HLA region is the human equivalent of the Major Histocompatibility ... that serve as the backbone of antigen presentation. The ... CD8+ T-cells, are expressed by genes located in the HLA-A, ...
Cached Medicine Technology:Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3The Past, Present and Future of HLA Typing 2The Past, Present and Future of HLA Typing 3
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... the business worldwide. This rapid growth includes increased hiring ... manufacturing efforts. The company has experienced average annual growth ... expects this growth to continue in the future as ... adoption. , “We are very pleased that ...
(Date:10/1/2014)... 2014 Farmington Company today announced ... mission and visual identity helping brokers, consultants and ... them to create greater benefit communication synergies. They ... on empowering customers to better leverage Farmington Company’s ... jewel of the rebrand is the refreshed tagline: ...
(Date:10/1/2014)... A new genetic finding from Duke Medicine suggests that ... depression might also be hard-wired to gain weight when ... disease. , An estimated 13 percent of people, all ... and knowing this could help them reduce heart disease ... and stress management. , "Genetic susceptibility, psychosocial stress and ...
(Date:10/1/2014)... Kennebunkport, Maine (PRWEB) October 01, 2014 ... autoimmune disorders in the U.S., according to figures from ... Autoimmune Related Diseases Association (AARDA), and many of them ... higher chance of having undiagnosed celiac disease. Gluten ... helping raise awareness of undiagnosed celiac disease by publishing ...
(Date:10/1/2014)... 2014 Diet Doc understands that many of ... weight and their dieting attempts could be easily sabotaged by ... hormone diet treatments into their programs as a way ... fast and effective weight loss results, it also allows patients ... to maintain their weight for the future. , Earlier versions ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... cancer patients who exhibit limited lymph node involvement may ... neoadjuvant chemotherapy before a mastectomy, according to researchers from ... , The findings were reported today at the ... Radiology and Oncology. , "Radiation after surgery has been ...
... can affect practice behavior in inquiries about patient mood ... study led by University of Rochester Medical Center researchers. ... or attitudes, are loathe to broach sensitive topics such ... professor of psychiatry at the Medical Center and lead ...
... 24 As Senators Barack,Obama and John McCain arrive ... be greeted by AIDS activists from across the,country demanding ... his first 100 days in office., On Friday, ... the debate -,AIDS activists will hold a demonstration and ...
... Cooper University,Hospital in Camden, N.J., has agreed ... interest, to settle allegations that it defrauded ... settlement resolves allegations that the hospital improperly,increased ... reimbursement,from the federal health care program. In ...
... training in 60s, 70s wards off loss that weakens ... -- Strength training can help people build muscle mass to ... age until they reach 80, a new study says. , ... , The Ball State University study, sponsored by a ...
... The U.S. Pharmacopeial (USP) Convention is pleased to ... Material (CRM), Dextromethorphan Hydrobromide. USP recently became the ... Standardization accreditation as producer of chemical CRMs. ... new class of reference standard that ensures improved ...
Cached Medicine News:Health News:Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation 2Health News:Personality can hamper a physician's assessment of depression 2Health News:AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy 2Health News:New Jersey Hospital to Pay $3.85 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare Reimbursement 2Health News:Boomers Should Add Muscle Before It's Too Late 2
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... Fast-Cath, Maximum, Maximum Xtra, and ... line of standard and specialty hemostasis ... recognized as the premier hemostasis introducers ... electrophysiology procedures including angiography, angioplasty, stenting, ...
... to close arteriotomies with ease and ... a simple trigger actvated mechanism, requires ... sheath gently locks onto the target ... site before, during, and after the ...
The Prostar XL 10 is a suture mediated closure system. It can be used with 10F sheath. It has two 3-0 braided polyester sutures and also has the safety of guidewire....
Medicine Products: